News
Innovative Medicines based on
ImmunoModulatory Biologics
-
Media Room
-
News
(September 1, 2021) IMBiologics successfully closes series A financing round with 13B KRW
-
- Date
- 2022-03-07 12:18:18
-
- View
- 1593
For more information, please visit : IMBiologics News (full article available in Korean)
- President(CEO) : Gyongsik Ha
- 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea